Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 8:9:937167.
doi: 10.3389/fmed.2022.937167. eCollection 2022.

COVID-19 vaccination reduces mortality in patients on maintenance hemodialysis

Affiliations

COVID-19 vaccination reduces mortality in patients on maintenance hemodialysis

Leszek Tylicki et al. Front Med (Lausanne). .

Abstract

Patients with chronic kidney disease on maintenance hemodialysis (HD) have a very high risk of death in the course of COVID-19. The aim of the study was to assess the effectiveness of COVID-19 vaccination to reduce the incidence of COVID-19 and the fatality rate in HD patients. A retrospective registry-based cohort study was performed in all HD adult patients in the Pomeranian Voivodeship. Vaccinations were carried out from January to April 2021 with mRNA vaccines, either BNT162b2 or mRNA-1273 with two-dose schedule. In the first analysis (2nd pandemic wave), 1,160 unvaccinated patients were included (59.7% males, 25.7% diabetic). In the second analysis (4th pandemic wave), 1,131 (59.4% male, 30.7% diabetic) individuals were included, 1,042 (92.13%) were fully vaccinated. Three hundred and fifteen HD patients (27.2%) were COVID-19 positive during the 2nd wave, and 6.9% (78/1,131) during the 4th wave. Within the fully vaccinated patients of the 4th wave, 60 were COVID-19 positive, 5.8 vs. 20.2% of unvaccinated COVID-19 positive patients in 2nd wave, respectively. COVID-19 incidence rate ratio (IRR) was 0.21 (4th wave-vaccinated vs. 2nd wave-unvaccinated) indicating a 79% reduction. The IRR between vaccinated and unvaccinated patients of the 4th wave was 0.28 in favor of vaccinated patients with 72% reduction. In the 2nd wave, 93 patients died as a result of COVID-19 (fatality rate: 29.5%). The fatality rate of fully vaccinated patients during the 4th wave was 6.7% (p = 0.004), while the fatality rate in the 4th wave within unvaccinated patients accounted for 11.1%. Significant clinical effectiveness of COVID-19 vaccination was demonstrated in a multicenter study in HD patients.

Keywords: COVID-19; fatality rate; incidence; maintenance dialysis; vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The comparison of COVID-19-free survival probability (%) between the three subgroups and the hazard ratio for COVID-19-free survival.

References

    1. Hilbrands LB, Duivenvoorden R, Vart P, Franssen CFM, Hemmelder MH, Jager KJ, et al. . COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplant. (2020) 35:1973–83. 10.1093/ndt/gfaa261 - DOI - PMC - PubMed
    1. Puchalska-Reglińska E, Debska-Slizien A, Biedunkiewicz B, Tylicki P, Polewska K, Rutkowski B, et al. . Extremely high mortality in COVID-19 hemodialyzed patients before the anti-SARS-CoV-2 vaccination era. Large database from the North of Poland. Pol Arch Intern Med. (2021) 131:643–8. 10.20452/pamw.16028 - DOI - PubMed
    1. Biedunkiewicz B, Tylicki L, Puchalska-Reglinska E, Debska-Slizien A. Analysis of experiences in preventing COVID-19 in hemodialysis centers of the north of poland before the era of vaccination. Int J Environ Res Public Health. (2022) 19:684. 10.3390/ijerph19020684 - DOI - PMC - PubMed
    1. Council E-E, Group EW. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. (2021) 36:87–94. 10.1093/ndt/gfaa314 - DOI - PMC - PubMed
    1. Grupper A, Sharon N, Finn T, Cohen R, Israel M, Agbaria A, et al. . Humoral response to the pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol. (2021) 16:1037–42. 10.2215/CJN.03500321 - DOI - PMC - PubMed